TipRanks
Advertisement
Advertisement

DE:2DT Stock Latest News

Amneal Pharmaceuticals initiated with an Outperform at Oppenheimer
The FlyAmneal Pharmaceuticals initiated with an Outperform at Oppenheimer
18d ago
AMRX
Chris Schott Initiates Buy on Amneal, Citing Lanreotide Launch and Biosimilar-Driven Growth Outlook Through 2027
PremiumRatings
Chris Schott Initiates Buy on Amneal, Citing Lanreotide Launch and Biosimilar-Driven Growth Outlook Through 2027
20d ago
AMRX
Amneal Pharmaceuticals announces FDA approval and launch of Lanreotide
PremiumThe Fly
Amneal Pharmaceuticals announces FDA approval and launch of Lanreotide
23d ago
AMRX
Amneal Pharmaceuticals price target raised to $20 from $16 at Barclays
PremiumThe Fly
Amneal Pharmaceuticals price target raised to $20 from $16 at Barclays
25d ago
AMRX
Leerink bullish on Amneal Pharmaceuticals, initiates with an Outperform
PremiumThe Fly
Leerink bullish on Amneal Pharmaceuticals, initiates with an Outperform
1M ago
AMRX
Amneal Pharmaceuticals initiated with an Outperform at Leerink
PremiumThe FlyAmneal Pharmaceuticals initiated with an Outperform at Leerink
1M ago
AMRX
Amneal registers to sell 28.94M shares of Class A common stock for holders
Premium
The Fly
Amneal registers to sell 28.94M shares of Class A common stock for holders
1M ago
AMRX
Amneal Pharmaceuticals resumed with an Overweight at JPMorgan
Premium
The Fly
Amneal Pharmaceuticals resumed with an Overweight at JPMorgan
2M ago
AMRX
Amneal Pharmaceuticals Completes Kashiv BioSciences Acquisition Financing
PremiumCompany Announcements
Amneal Pharmaceuticals Completes Kashiv BioSciences Acquisition Financing
2M ago
8K
AMRX
Amneal Pharmaceuticals price target raised to $25 from $23 at UBS
PremiumThe Fly
Amneal Pharmaceuticals price target raised to $25 from $23 at UBS
2M ago
AMRX
Amneal Pharmaceuticals Reprices Term Loans to Reduce Interest
PremiumCompany Announcements
Amneal Pharmaceuticals Reprices Term Loans to Reduce Interest
2M ago
8K
AMRX
Amneal Pharmaceuticals price target raised to $25 from $23 at UBS
PremiumThe Fly
Amneal Pharmaceuticals price target raised to $25 from $23 at UBS
2M ago
AMRX
Amneal Pharmaceuticals price target raised to $25 from $23 at UBS
PremiumThe FlyAmneal Pharmaceuticals price target raised to $25 from $23 at UBS
2M ago
AMRX
Amneal Pharmaceuticals’ Earnings Call Signals Strong Growth
Premium
Company Announcements
Amneal Pharmaceuticals’ Earnings Call Signals Strong Growth
2M ago
AMRX
Amneal Stockholders Approve Kashiv BioSciences Acquisition Plans
Premium
Company Announcements
Amneal Stockholders Approve Kashiv BioSciences Acquisition Plans
2M ago
8K
AMRX
Amneal Pharmaceuticals price target raised to $21 from $19 at Goldman Sachs
PremiumThe Fly
Amneal Pharmaceuticals price target raised to $21 from $19 at Goldman Sachs
2M ago
AMRX
Amneal Raises 2026 Outlook After Strong Q2 Results
PremiumCompany Announcements
Amneal Raises 2026 Outlook After Strong Q2 Results
2M ago
8K
AMRX
Amneal Pharmaceuticals reports Q2 adjusted EPS 30c, consensus 23c
PremiumThe Fly
Amneal Pharmaceuticals reports Q2 adjusted EPS 30c, consensus 23c
2M ago
AMRX
Amneal Pharmaceuticals raises 2026 adj EPS view to 96c-$1.06 from 95c-$1.05
PremiumThe Fly
Amneal Pharmaceuticals raises 2026 adj EPS view to 96c-$1.06 from 95c-$1.05
2M ago
AMRX
Amneal receives FDA approval for additional iohexol strengths, presentations
PremiumThe FlyAmneal receives FDA approval for additional iohexol strengths, presentations
3M ago
AMRX
Amneal Pharmaceuticals price target raised to $23 from $19 at UBS
Premium
The Fly
Amneal Pharmaceuticals price target raised to $23 from $19 at UBS
3M ago
AMRX
FDA selects seven participants for PreCheck Pilot Program
Premium
The Fly
FDA selects seven participants for PreCheck Pilot Program
3M ago
LLY
AMRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >